These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19491255)

  • 1. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
    Raina D; Ahmad R; Joshi MD; Yin L; Wu Z; Kawano T; Vasir B; Avigan D; Kharbanda S; Kufe D
    Cancer Res; 2009 Jun; 69(12):5133-41. PubMed ID: 19491255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
    Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
    Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 oncoprotein is a druggable target in human prostate cancer cells.
    Joshi MD; Ahmad R; Yin L; Raina D; Rajabi H; Bubley G; Kharbanda S; Kufe D
    Mol Cancer Ther; 2009 Nov; 8(11):3056-65. PubMed ID: 19887552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells.
    Uchida Y; Raina D; Kharbanda S; Kufe D
    Cancer Biol Ther; 2013 Feb; 14(2):127-34. PubMed ID: 23114713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.
    Raina D; Kosugi M; Ahmad R; Panchamoorthy G; Rajabi H; Alam M; Shimamura T; Shapiro GI; Supko J; Kharbanda S; Kufe D
    Mol Cancer Ther; 2011 May; 10(5):806-16. PubMed ID: 21421804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
    Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D
    Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of the tumor-specific antigen-derived synthetic mucin 1 peptide: A potential candidate for the targeting of breast carcinoma.
    Okarvi SM; Al Jammaz I
    Nucl Med Biol; 2016 Jul; 43(7):403-9. PubMed ID: 27179249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation.
    Hasegawa M; Sinha RK; Kumar M; Alam M; Yin L; Raina D; Kharbanda A; Panchamoorthy G; Gupta D; Singh H; Kharbanda S; Kufe D
    Clin Cancer Res; 2015 May; 21(10):2338-47. PubMed ID: 25712682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.
    Zhou Y; Rajabi H; Kufe D
    Mol Pharmacol; 2011 May; 79(5):886-93. PubMed ID: 21346142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
    Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
    Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate.
    Panchamoorthy G; Jin C; Raina D; Bharti A; Yamamoto M; Adeebge D; Zhao Q; Bronson R; Jiang S; Li L; Suzuki Y; Tagde A; Ghoroghchian PP; Wong KK; Kharbanda S; Kufe D
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular MUC1 peptides inhibit cancer progression.
    Bitler BG; Menzl I; Huerta CL; Sands B; Knowlton W; Chang A; Schroeder JA
    Clin Cancer Res; 2009 Jan; 15(1):100-9. PubMed ID: 19118037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target.
    Raina D; Agarwal P; Lee J; Bharti A; McKnight CJ; Sharma P; Kharbanda S; Kufe D
    PLoS One; 2015; 10(8):e0135156. PubMed ID: 26267657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.
    Li Y; Yi H; Yao Y; Liao X; Xie Y; Yang J; Yan Z; Wang L; Lu S; Kuang Y; Gu M; Fei J; Wang Z; Huang L
    PLoS One; 2011 Apr; 6(4):e19102. PubMed ID: 21533058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.
    Kufe DW
    Oncogene; 2013 Feb; 32(9):1073-81. PubMed ID: 22580612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.
    Li Y; Yu WH; Ren J; Chen W; Huang L; Kharbanda S; Loda M; Kufe D
    Mol Cancer Res; 2003 Aug; 1(10):765-75. PubMed ID: 12939402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells.
    Jin C; Rajabi H; Pitroda S; Li A; Kharbanda A; Weichselbaum R; Kufe D
    PLoS One; 2012; 7(7):e39432. PubMed ID: 22792175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein.
    Yin L; Ahmad R; Kosugi M; Kawano T; Avigan D; Stone R; Kharbanda S; Kufe D
    Cancer Biol Ther; 2010 Sep; 10(5):483-91. PubMed ID: 20592495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
    Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
    J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells.
    Kosugi M; Ahmad R; Alam M; Uchida Y; Kufe D
    PLoS One; 2011; 6(11):e28234. PubMed ID: 22140559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.